Ready-to-Use Multiplex Assays: Twelve qPCR vials (5-plex format) optimized for consistent and sensitive amplification.
Built-in Internal Amplification Control (Cy5.5): Every 5-plex mix includes an Internal Control detected on the Cy5.5 channel, ensuring real-time monitoring of amplification performance and PCR inhibition.
Positive Control: Whole genome libraries Normalized to 500 genomic copies/ul
Exogenous Control (EC): Spike-in Non-Pathogen Whole organism controls to confirm extraction and amplification efficiency.
Comprehensive Documentation: Includes detailed protocols, troubleshooting guide, and Certificate of Analysis (COA).
Comprehensive Detection of Respiratory Bacterial and Viral Pathogens
- Bacterial Targets: Acinetobacter baumannii, Actinotignum schaalii, Aerococcus urinae, Bacteroides fragilis, Citrobacter freundii/braakii/koseri, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella (Enterobacter) aerogenes, Morganella morganii, Mycoplasma genitalium, Mycoplasma hominis, Prevotella bivia, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Staphylococcus saprophyticus, Streptococcus agalactiae (Group B), Streptococcus pyogenes (Group A), Ureaplasma urealyticum/parvum
- Fungal Targets: Candida albicans, Candida auris, Candida glabrata, Candida parapsilosis, Candida tropicalis, Epidermophyton floccosum, Trichophyton rubrum
- AMR: Beta-lactamase (CTX-M Group 1), Beta-lactamase (SHV), Carbapenem resistance (OXA), Fluoroquinolone resistance (qnrA / qnrB / qnrS), Fluoroquinolone resistance (gyrA), Methicillin resistance (mecA), Sulfonamide resistance (sul1), Tetracycline resistance (tetB, tetM), Trimethoprim resistance (dfrA1), Vancomycin resistance (VanA, VanB, VanM)
- Controls: Internal Control (RNase P), Exogenous Control (EC)
Covers 26 bacterial targets, 7 fungal targets, 13 antimicrobial resistance markers, and 2 internal controls (48 total targets) for comprehensive urinary tract infection (UTI), urogenital pathogen, and antimicrobial resistance profiling.
